Drug Safety Project

The drug supply chain has become increasingly complex in recent years. Today’s prescription and over-the-counter remedies originate in factories all over the world, moving into American homes through supply chains that can involve numerous processing plants, manufacturers, suppliers, brokers, packagers, and distributors. This increases the risk that substandard or counterfeit medicines could reach patients and contributes to shortages of essential medicines. Pew’s work on drug safety helps to ensure a safe, reliable pharmaceutical manufacturing and distribution system.

Our Work

View All
  • Opportunities for Drug Serialization to Make U.S. Drug Supply Chain Safer, More Secure

    As repackagers, shippers, and businesses at every link in the supply chain work with regulators to implement the law, they have the opportunity to use serial numbers to provide even stronger protections against counterfeit, tainted, or stolen drugs. Read More

  • Drug Compounding

    Traditional drug compounding—the creation of customized medicines to meet a patient's unique needs—has always been a part of pharmacy practice. But dramatic expansion of the sector in recent decades has resulted in production conditions on a scale closer to pharmaceutical manufacturing yet without the same oversight or quality standards. In fact, since 2001, over 25 pharmacy... Read More

  • Drug Shortages

    Drug shortages are an ongoing U.S. public health crisis. New annually reported incidents grew dramatically from 117 in 2007 to a high of 255 in 2011. Although such reports have begun to decline, unresolved drug shortages persist. In 2012, the United States experienced 456 active drug shortages, many of them crucial medicines used in cancer treatment, surgery, and intensive care. Read More

Media Contact

Linda Paris

Officer, Communications

202.540.6354